b-arrestins are expressed proteins that were first described, and are well-known, as negative regulators of G protein-coupled receptor signaling. Penehyclidine hydrochloride (PHC) is a new anti-cholinergic drug that can inhibit biomembrane lipid peroxidation, and decrease cytokines and oxyradicals. However, to date, no reports on the effects of PHC on b-arrestin-1 in cells have been published. The aim of this study was to investigate the effect of PHC on b-arrestin-1 expression in lipopolysaccharide (LPS)-induced human pulmonary microvascular endothelial cells (HPMEC). Cultured HPMEC were pretreated with PHC, followed by LPS treatment. Muscarinic receptor mRNAs were assayed by real-time quantitative PCR. Cell viability was assayed by the methyl thiazolyl tetrazolium (MTT) conversion test. The dose and time effects of PHC on barrestin-1 expression in LPS-induced HPMEC were determined by Western blot analysis. Cell malondialdehyde (MDA) level and superoxide dismutase (SOD) activity were measured. It was found that the M 3 receptor was the one most highly expressed, and was activated 5 min after LPS challenge. Furthermore, 2 mg/mL PHC significantly upregulated expression of b-arrestin-1 within 10 to 15 min. Compared with the control group, MDA levels in cells were remarkably increased and SOD activities were significantly decreased in LPS pretreated cells, while PHC markedly decreased MDA levels and increased SOD activities. We conclude that PHC attenuated ROS injury by upregulating b-arrestin-1 expression, thereby implicating a mechanism by which PHC may exert its protective effects against LPS-induced pulmonary microvascular endothelial cell injury.
Introduction
Oxidative stress is an imbalance between oxidants and antioxidants (1) . Oxidative stress can cause serious damage to cellular structure and function, and can also modulate cell signaling pathways and gene expression. Biological lipid oxidation produces oxidative stress. Malondialdehyde (MDA) is the principal product of polyunsaturated fatty acid peroxidation. This aldehyde is a highly toxic molecule and should be considered as more than just a marker of lipid peroxidation (2) . Superoxide dismutase (SOD) is an endogenous enzyme responsible for the dismutation of superoxide radicals. SOD plays a pivotal role in protecting tissues from damage by oxidative stress by scavenging superoxide anions, which prevents the formation of other more potent oxidants such as peroxynitrite and hydroxyl radicals (3) .
Arrestins are expressed proteins that were first described, and are well-known as negative regulators of G protein-coupled receptor (GPCR) signaling (4) . There are four members of the arrestin family (arrestin-1 to -4). Arrestin-1 and arrestin-4, termed rod and cone arrestin, are expressed in photoreceptor cells and terminate rhodopsin and cone opsin signaling. Arrestin-2 (also called b-arrestin-1) and arrestin-3 (also called b-arrestin-2) are ubiquitously distributed and bind hundreds of different GPCRs (5, 6) . Arrestins play key roles in the regulation of multiple GPCR-dependent and -independent signaling pathways. Arrestins bind to the activated and phosphorylated state of these receptors, consequently blocking the ability of the receptors to activate G protein (7) . b-arrestin-1 serves as a multifunctional adaptor protein that mediates receptor desensitization, receptor internalization, and links GPCRs to downstream pathways (8) . Studies have also shown that, depending on the cellular context and receptor examined, b-arrestin-1 either mediates or inhibits receptor signaling (9) . Furthermore, recent studies have also shown that b-arrestins function to negatively regulate the inflammatory response induced by lipopolysaccharide (LPS) (10) . It has also been demonstrated that b-arrestins can regulate LPS-induced signaling and pro-inflammatory gene expression (11) .
Penehyclidine hydrochloride (PHC) is a new anticholinergic drug derived from hyoscyamine, which is an anticholinergic agent with a high degree of selectivity for M 1 and M 3 receptor subtypes (12) . PHC could improve the outcome in patients with soman poisoning, and appears efficacious in improving the symptoms and the lung function of patients with chronic obstructive pulmonary disease, a lung disease defined by persistently poor airflow as a result of breakdown of lung tissue and dysfunction of the small airways (13, 14) . Other than the anticholinergic effects, PHC could inhibit biomembrane lipid peroxidation, and decrease cytokines and oxyradicals. Shen et al. (15) reported that PHC counteracted lipid peroxidation as indicated by reduced MDA content and increased activity of SOD. Moreover, our recent studies demonstrated that PHC could attenuate NO production and iNOS expression by suppressing the activation of the p38 MAPK pathway, and that b-arrestin-1 is closely related to p38 MAPK signaling pathway (16, 17) . However, to date, no reports on the effects of PHC on b-arrestin-1 in cells have been published. This study aimed to investigate the effect of PHC on b-arrestin-1 expression in LPS-induced human pulmonary microvascular endothelial cells (HPMEC), and explore the biological effect of PHC on LPS-induced MDA production and SOD activity in HPMEC in order to lay a solid foundation for future research of PHC in cells.
Material and Methods

Material
PHC was provided by Lisite Corporation (China). LPS (Escherichia coli 0111: B4) and RPMI 1640 were purchased from Sigma (USA). MDA and SOD assay kits were purchased from Jiancheng Biologic Project Company (China). Anti-b-arrestin-1 antibody was purchased from Abcam Incorporated (UK) (rabbit, Ab32099, 1:1000) and anti-b-actin antibody was provided by Santa Cruz Biotechnology (USA) (rabbit, Sc-1616r, 1:1000).
Cell lines and cell culture
HPMEC were purchased from the Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China) and were cultured in RPMI 1640, 10% standard newborn calf serum, 50 mg/mL streptomycin, 50 IU/mL penicillin, and 2 mM glutamine in a humidified, 5% CO 2 atmosphere at 376C (E191TC, SIM CO 2 Incubator, USA).
Real-time quantitative PCR analysis
Cells were harvested and total RNA was extracted using Trizol Reagent (Invitrogen Life Technologies, USA) according to the manufacturer's instructions. Two micrograms total RNA was reverse transcribed using a Toyobo First-Strand cDNA synthesis kit (GeneCopoeia Inc., USA). Reverse transcription was performed at 706C for 5 min, 06C for 3 min, 426C for 30 min, and 806C for 5 min. The mRNA levels of M 1 , M 2 , M 3 , and M 4 receptor subtypes were measured by quantitative PCR. qPCR amplifications were performed in triplicate using the SYBR Green I assay (Toyobo Inc., Japan). The reactions were carried out in 25-mL reaction solution containing 2.0 mL cDNA, 2.0 mL mixed gene-specific forward and reverse primers (10 mM each), 12.5 mL 26 qPCR Mix and 8.5 mL double-distilled H 2 O. The amplification reaction was carried out in an initial 1-min predenaturation at 956C, 40 cycles at 956C for 15 s, 586C for 20 s, 726C for 20 s, followed by the protocol for the melting curve with an increase of 16C between each 20 s from 726 to 956C. b-actin gene was used as an internal control for normalization of RNA quantity and quality differences in all samples. For each sample analyzed, qPCR provides a cycle time (CT) value where the fluorescence signal is detectable. All CTs were dependent on the starting amount of cDNA. The b-actin CT value was used to confirm the starting amount of cDNA in PCR quantifications. Gene expression was quantified using a modification of the 2 -DDCt method. Primer sequences were designed using the NCBIPrimer BLAST online tool and synthesized commercially (Invitrogen Biotechnology Co., Ltd., China). The sequences of the primers used in the present study were as follows: 
Cell viability assay
Cell viability was assessed by the methyl thiazolyl tetrazolium (MTT) conversion test. Briefly, HPMECs were seeded on 96-well microtiter plates (20,000 cells/well) and allowed to adhere for 24 h. The cells were incubated without or with PHC (0.2, 1, 2, 10, 20, 100, 200 mg/mL) for 1 h followed by induction with LPS (0.1 mg/mL) for 24 h. We also added a PHC alone group (200 mg/mL) in order to investigate the cytotoxic effect of PHC. After incubation, 20 mL/well MTT (Amresco Inc., USA) solution (5 mg/mL) was added and incubated for 4 h. The medium was aspirated and replaced with 150 mL/well dimethyl sulfoxide solution (DMSO). The plates were shaken for 10 min, and absorbance was determined at 490 nm using an automated microplate reader (RT-6000, Shenzhen Rayto Life Science Limited Company, China). Each assay was performed on five plates.
Western blot analysis
Equal amounts of proteins (40 mg) were loaded onto SDS-polyacrylamide gels, transferred to nylon membranes, and incubated with primary antibody overnight at 46C. Excess antibody was then removed by washing the membranes in PBS-0.05% Tween-20, and the membranes were incubated in secondary antibodies for 30 min. After washing in PBS-0.05% Tween 20, the bands were detected by enhanced chemiluminescence and the density of the individual bands was quantified by densitometry using the AlphaEase FC software (Alpha Innotech Inc., USA).
Measurement of MDA and SOD
Cells were collected to examine MDA content and SOD activity. Absorbance was measured at 532 nm (MDA) and 550 nm (SOD), on a DU-530 spectrophotometer (Beckman Instruments Inc., USA). MDA was measured after reaction with thiobarbituric acid using the MDA assay kit; SOD was determined by a method using inhibition of superoxide anions produced by the action of xanthine oxidase on xanthine using the SOD assay kit. MDA concentrations are reported as nmol/mL. SOD activities are reported in units per milliliter (U/mL).
Statistical analysis
Data are reported as means±SD. Analysis of variance (ANOVA) and the Student-Newman-Keuls Qtest were used for statistical comparison of values among all groups. A significant difference was presumed for a probability value of ,0.05.
Results
LPS-induced HPMEC muscarinic receptor 3 activation
We identified muscarinic receptor subtypes M 1 -M 4 in HPMEC, and found that the M 3 receptor was the most highly expressed of the four (Figure 1) . We then measured M 3 receptor expression in LPS-induced HPMEC at 5-min time points from 5 to 30 min. It was shown that, in a time-dependent manner, maximum expression of M 3 receptor was induced at 5 min and then declined gradually from 10 to 30 min (Figure 2 ).
MTT assays
Mitochondrial succinate dehydrogenase in living cells converts MTT into visible formazan crystals during incubation. The formazan crystals were then solubilized in DMSO. However, these reactions do not occur in dead cells. Absorbance thus represents the number of surviving cells. As shown in Figure 3 , cell survival significantly decreased after LPS challenge, and PHC (200 mg/mL) alone exerted no effect on cell survival. Compared with the LPS group, there was a measurable increase in absorbance in all PHC groups. However, the increase was significant only in the 2 and 1 mg/mL PHC groups. 
LPS-induced oxidative stress and its modulation by PHC
To assess the antioxidant effects of PHC, we preincubated cells with 2 mg/mL PHC for 1 h, followed by 0.1 mg/mL LPS treatment for 1 h. Compared with the control group, the MDA content in cells was remarkably increased and SOD activity was significantly decreased in the LPS group (both P,0.01). Two microgram per milliliter PHC pretreatment markedly decreased LPSinduced MDA content and enhanced SOD activities ( Figure 6 ). In addition, PHC alone had no effect on basal oxidative status in cells.
Discussion
The present study was undertaken to elucidate the biological effect of PHC on b-arrestin-1 expression, MDA production and SOD activity in LPS-induced HPMEC. To our knowledge, this is the first report regarding the effect of PHC on b-arrestin-1 expression at the cellular level.
GPCRs are the largest family of cell surface receptors. GPCRs can be activated by multiple ligands and exhibit the capacity to couple to numerous intracellular signal transduction pathways (18) . Oxidative stresses have recently been shown to be generated by agonists of several members of the GPCR superfamily (19) . Muscarinic acetylcholine receptors, which are linked to a variety of intracellular second messenger systems through G-proteins, belong to the GPCR superfamily. Muscarinic receptors can regulate numerous central and peripheral physiological functions including control of memory, arousal, motor activity, and heart rate (20) . Muscarinic receptors are divided into five distinct subtypes M 1 -M 5 , and we determined M 1 -M 4 subtypes in HPMEC in this study. The M 3 receptor was the most highly expressed of the four subtypes. Furthermore, M 3 receptor activation occurred at 5 min after LPS challenge, at the same time as an increase in MDA level and reduction in SOD activity, which indicated lipid peroxidation damage emerged at 60 min and suggested that M 3 activation may lead to oxidative stress generation in LPS-induced HPMEC.
b-arrestins are scaffolding proteins originally noted for their role in GPCR desensitization (21) . Recent studies have suggested that b-arrestins also play a role in cell signaling pathways, and in gene expression (22, 23) . The muscarinic receptor is a kind of GPCR, while b-arrestin-1 is known as a terminator of GPCR signaling. It is possible that b-arrestin-1 decreased oxidative stress through blocking M 3 receptors and its downstream signal pathway.
MDA is suggested to indicate induction of ROS activity and oxidative tissue damage (24) . In this study, reduction in MDA concentration indicated less lipid peroxidation damage in the PHC group compared to the LPS group. SOD is the major intracellular antioxidant with multiple biological functions (25) . With an increase in the antioxidant enzyme SOD, it could reasonably be expected that cellular biochemical markers of oxidative stress would be reduced after PHC treatment. As assessed by the MTT assay, the effects of PHC on these indices were not attributable to PHC cytotoxicity.
It has been reported that anisodamine, a widely prescribed muscarinic receptor antagonist, could exert antiflammatory effects through upregulating b-arrestin-1 (26) . PHC, which has fewer cardiovascular side effects than other anticholinergics, may exert antioxidant effects through upregulating b-arrestin-1.
Yan et al. (27) studied the effect of PHC on strips of intestine isolated from guinea pigs, and found that PHC can effectively relieve intestine spasm in vitro at concentrations of 0.2, 2.0, 20.0 mg/mL. We also carried out MTT experiments to determine the optimum concentration based on the above study, and the concentrations of PHC (1 to 10 mg/mL) were chosen for b-arrestin-1 measurement. From the results of Western blot analysis, 2 mg/mL PHC had a significant protective effect on LPSinduced HPMEC compared with the other doses. Furthermore, the time of maximum peak of PHC on barrestin-1 expression in LPS-induced HPMEC was between 10 and 15 min.
We conclude that PHC intervention had a beneficial protective effect, at an appropriate dose, on LPS-induced HPMEC. Its mechanisms of action probably involve the upregulation of b-arrestin-1 expression and suppression of lipid peroxidation. Human pulmonary microvascular endothelial cells were pre-incubated with PHC for 1 h and treated with 0.1 mg/mL LPS for 1 h. LPS treatment significantly induced MDA increase and SOD decrease, which was attenuated by PHC pretreatment. In addition, PHC alone had no effect on basal MDA and SOD levels. Data are reported as means±SD. *P,0.01, compared to control; # P,0.05, compared to LPS treatment (ANOVA).
However, the current study has some limitations that need to be addressed. The effect of PHC on oxidative stress is attributable to either the inhibitory effects of PHC on M 3 receptors, or blocking M 3 receptor's downstream signal pathway through upregulating b-arrestin-1. Future studies would benefit from assessments of b-arrestin-1 or M 3 receptor function using specific siRNAs.
